Evaluation of anti-vascular therapy with texture analysis

被引:0
|
作者
Chen, G [1 ]
Jespersen, S
Pedersen, M
Pang, Q
Horsman, MR
Jorgensen, HS
机构
[1] Aarhus Univ Hosp, MR Res Ctr, DK-8200 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Expt Oncol, DK-8000 Aarhus, Denmark
[3] Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, Jinan 250021, Peoples R China
关键词
magnetic resonance imaging; texture analysis; carcinoma; boot strap statistics;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Texture analysis can be used to identify and discriminate between objects in an image and has already been used for the characterization of diseases. The present study evaluated the potential of texture analysis for monitoring tumor cell viability during treatment with an anti-vascular drug. Materials and Methods: Texture analysis of T-2-weighted magnetic resonance images of C3H mammary carcinomas in mice was used to study tumor cell viability during treatment with the anti-vascular drug combretastatin A-4 disodium phosphate (CA4DP). Texture analysis was done by MaZda((R)), and boot strap statistics were used to analyze the results. Results: The results revealed significant differences in the textures of T-2-weighted images when non-tumor tissue and tumor tissue were compared. Furthermore, selected texture parameters were significantly different when image data from before and after CA4DP administration were analyzed. Conclusion: Texture analysis is helpful in the diagnosis of different types of tissues, especially when these tissues can not be recognized by human observers. Some functional changes, such as perfusion changes in the tumor, can also be detected by texture analysis.
引用
收藏
页码:3399 / 3405
页数:7
相关论文
共 50 条
  • [21] Frequentist Analysis of Death Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Reply
    Mbekeani, Joyce N.
    Weiss, Rebecca
    Parsikia, Afshin
    JAMA OPHTHALMOLOGY, 2020, 138 (05) : 588 - 588
  • [22] Human endothelial progenitor cells: A new target for anti-vascular therapy
    Ben Rahoma, Ghada
    Tuli, Neha
    Maniyar, Rachana
    Chakraborty, Sanjukta
    Singh, Sarnath
    Mittelman, Abraham
    Tiwari, Raj K.
    CANCER RESEARCH, 2017, 77
  • [23] Anti-Vascular Endothelial Growth Factor Therapy and Renal Thrombotic Microangiopathy
    Sorenson, Christine M.
    Sheibani, Nader
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (08) : 1082 - 1082
  • [24] Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity
    VanderVeen, Deborah K.
    Cataltepe, Sule U.
    SEMINARS IN PERINATOLOGY, 2019, 43 (06) : 375 - 380
  • [25] Anti-vascular endothelial growth factor therapy in the era of personalized medicine
    Luis R. Féliz
    Apostolia M. Tsimberidou
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 1 - 12
  • [26] Anti-vascular endothelial growth factor therapy for diabetic macular edema
    Boyer, David S.
    Hopkins, J. Jill
    Sorof, Jonathan
    Ehrlich, Jason S.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2013, 4 (06) : 151 - 169
  • [27] Current status of anti-vascular endothelial growth factor therapy in Europe
    Wolf, Sebastian
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2008, 52 (06) : 433 - 439
  • [28] Effect of Anti-Vascular Endothelial Growth Factor Therapy on Corneal Nerves
    Goldhardt, Raquel
    Batawi, Hatim Ismail M.
    Rosenblatt, Mark
    Lollett, Ivonne V.
    Park, Jasmine J.
    Galor, Anat
    CORNEA, 2019, 38 (05) : 559 - 564
  • [29] Anti-Vascular Endothelial Growth Factor Therapy as an Adjunct to Diabetic Vitrectomy
    Karimov, Mushfig
    Akhundova, Lala
    OPEN OPHTHALMOLOGY JOURNAL, 2021, 15 : 137 - 143
  • [30] Current status of anti-vascular endothelial growth factor therapy in Europe
    Sebastian Wolf
    Japanese Journal of Ophthalmology, 2008, 52 : 433 - 439